After 13 months, the rats begin to show signs of dementia including reduced cognitive ability and memory impairment (McGill University, 2010).
Amyloid B. immunotherapy
Past research
Past research on the effects of active or passive a? immunization on a? buildup and AD progression provided evidence that such immunization "protects against the progressive loss of synaptophysin in the hippocampal molecular layer and frontal neocortex of a transgenic mouse model of AD" (Buttini & al, 2005). This provided further support for the amyloid hypothesis.
Current research
Since the discovery of a? immunotherapy effectiveness in the treatment of AD in mice, the AN1792 a? vaccine was developed and tested on humans (Lemere & Masliah, 2010). Unfortunately, clinical trials were discontinued when around 6% of the subjects developed meningoencephalitis (Lemere & Masliah, 2010). However, since some subjects showed improvements in a? plaque clearance, several new a? immunotherapies have been developed and are currently undergoing clinical trials (Lemere & Masliah, 2010). Based on preliminary results from these clinical trials, scientists predict that a? immunotherapy will be most effective in "preventing or slowing the progression of AD when patients are immunized before or in the very earliest stages" of the onset of AD (Lemere & Masliah, 2010). Therefore, current research is also focused on identifying biomarkers to predict the "presymptomatic" stages of AD (Lemere & Masliah, 2010).
Conclusion
Research on AD has made tremendous progress in the past decade, strengthening the amyloid hypothesis and providing evidence to support the development of a? immunotherapies. Further studies taking advantage of the a? rat model may provide more clues to direct the development of effective a? immunotherapies. In addition, anti-inflammatory medications and therapies should be considered for patients with AD, since numerous studies show a link between inflammation reduction and improvement in AD symptomatology.
The future also shows exciting promise for novel approaches to AD treatment. One new causal theory...
ALZHEIMER'S DISEASE Examining the potential use of beta secretase enzymes in the treatment of Alzheimer's Disease Examining the potential use of beta secretase enzymes in the treatment of Alzheimer's Disease Efforts to develop a drug for Alzheimer's disease, which mostly affect people in older age, have not been successful. Instead, most of the treatments offered often target the behavioral symptoms of the affected individual, but not the cause of the disease. The occurrence
Alzheimer Healthy Community PLANNED, PERSONALIZED CARE Alzheimer's Healthy Community Dog-Assisted Therapy for Older People with Dementia A review of nine studies on the subject produced loose conclusions on the value of this type of therapy (Perkins et al., 2008). They, however, established a trend, indicating increased social behavior and decreased agitation when dogs were in the company of the respondents. This improvement in social behavior was unrelated with the severity of the respondents' dementia.
What is worth noting here is the fact that behavior disturbances, ranging in severity from repeated questioning to physical violence, are common (National Institute of Mental Health, 1989). It is unclear whether Alzheimer's disease represents a single entity or several variants. Some experts believe that there are distinct subtypes of Alzheimer's disease, such as Lewy body disease (in which the signs of Parkinson's disease, visual hallucinations or alterations in alertness
Some treatments may actually help with the disease. Diets and dietary supplements Eating vegetables like broccoli and spinach may help older women [and probably men] retain some memory abilities later on, while avoiding obesity in middle age lowers the risk of later Alzheimer's disease in both sexes, new studies suggest." The effect of the vegetables probably comes from the antioxidants and B. vitamins they contain (Ritter, 2004). Herbal remedies and other dietary
Alzheimer's Disease currently affects more than four million Americans. Alzheimer's is a disease characterized by the progressive degeneration of areas within the brain, resulting in cognitive and physical decline that will eventually lead to death. It is important to emphasize that Alzheimer's disease (AD) is not a normal part of aging. Although AD typically appears in those over sixty-five, it is a neurodegenerative disease, quite distinct from any aging-related cognitive
More is learned every day in the field of medicine and nursing, and articles such as this one serve to point out that there is much more that needs to be learned. Serving the elderly population with Alzheimer's disease and treating them for their problems is often quite difficult, but the information in the article regarding what behaviors to look for in individuals that cannot express their pain verbally
Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.
Get Started Now